Helen Sabzevari
President & Chief Executive Officer Precigen
Seminars
Thursday 17th September 2026
Panel Discussion: Accelerating Veinto-Vein Time through Innovative QC Testing Strategies
2:35 pm
- Exploring rapid sterility testing methods, including ATP release assays and NGS-based microbial detection, to reduce traditional 7-day timelines
- Implementing rapid QC testing to accelerate vein-to-vein time without compromising safety and regulatory compliance
- Highlighting emerging technologies demonstrating rapid, reliable testing to support clinical and commercial qc workflows
Wednesday 16th September 2026
Developing the UltraCAR-T® Platform to Expand Patient Access & Drive Scalable Manufacturing in Next-Generation Cell Therapy
9:50 am
- Designing multi-component, non-viral UltraCAR-T therapies to overcome biological and delivery limitations
- Reducing cost, time, and complexity to make precision medicine broadly accessible
- Demonstrating early Phase 2 efficacy, safety, and rapid treatment delivery in AML patients, enabled by overnight UltraCAR-T manufacturing
